Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(4′-fluorophenyl)-3-(4′phenylphenoxy)propyl])sarcosine

This publication has 31 references indexed in Scilit:

• Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout mice
  Synapse, 2002
• N[3‐(4′‐fluorophenyl)‐3‐(4′‐phenylphenoxy)propyl]sarcosine (NFPS) is a selective persistent inhibitor of glycine transport
  British Journal of Pharmacology, 2001
• Glycine transport inhibitors as potential antipsychotic drugs
  Emerging Therapeutic Targets, 2001
• Discovery and SAR of Org 24598—A Selective Glycine Uptake Inhibitor
  Bioorganic & Medicinal Chemistry Letters, 2001
• N-Methyl-D-aspartate (NMDA) receptor-based treatment approaches in schizophrenia: the first decade
  International Journal of Neuropsychopharmacology, 2000
• Differential effects of the tricyclic antidepressant amoxapine on glycine uptake mediated by the recombinant GLYT1 and GLYT2 glycine transporters
  British Journal of Pharmacology, 2000
• Generation and Characterisation of Stable Cell Lines Expressing Recombinant Human N‐Methyl‐d‐Aspartate Receptor Subtypes
  Journal of Neurochemistry, 1996
• Regional Distribution and Developmental Variation of the Glycine Transporters GLYT1 and GLYT2 in the Rat CNS
  European Journal of Neuroscience, 1995
• Cloned Glutamate Receptors
  Annual Review of Neuroscience, 1994
• Two glycine transporter variants with distinct localization in the CNS and peripheral tissues are encoded by a common gene
  Neuron, 1993